Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha
about
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesisInterleukin 1 is processed and released during apoptosisAutoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseasesIntracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblastsRedox control of senescence and age-related diseaseAlternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activitiesCell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicityp-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 beta converting enzymeInterleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanismInterleukin-1alpha is a regulator of the blood-testis barrierIntracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammationListeriolysin O-dependent bacterial entry into the cytoplasm is required for calpain activation and interleukin-1 alpha secretion in macrophages infected with Listeria monocytogenesDC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells.Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri.Distinct contributions of interleukin-1α (IL-1α) and IL-1β to innate immune recognition of Pseudomonas aeruginosa in the lung.Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory diseaseAcute inducible ablation of GRP78 reveals its role in hematopoietic stem cell survival, lymphogenesis and regulation of stress signaling.TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lungInflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system.Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1αThe epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation.Membrane-Permeable Calpain Inhibitors Promote Rat Oral Mucosal Epithelial Cell Proliferation by Inhibiting IL-1α SignalingTherapeutic potential of targeting IL-1 and IL-18 in inflammation.Regulation and physiological roles of the calpain system in muscular disordersHuman S100A7 Induces Mature Interleukin1α Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis.The host cytokine responses and protective immunity in oropharyngeal candidiasis.Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alphaThe 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propieceA comprehensive map of the toll-like receptor signaling network.The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.Uric acid as a danger signal in gout and its comorbiditiesDecoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.Caspases as therapeutic targets.Redox-control of the alarmin, Interleukin-1αRedox control of the senescence regulator interleukin-1α and the secretory phenotype.Interleukin 1α and the inflammatory process.Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy
P2860
Q24306415-AE50B206-8BC9-4071-9AE1-521616DFF331Q24315035-0739E568-6F71-4213-99AE-79377488B6B3Q24322759-6235189B-88C1-45FA-A3C2-11B0E89400C1Q24676706-DEB01C61-30E9-468E-93C0-02C7C9811995Q28074230-BA296F6D-750F-43FD-A3E5-B29F5205D141Q28205820-41F50C40-6612-48EC-BDDA-A6A2F54DE4D1Q28379568-724B089D-0D41-41D0-B352-E64DB9B98F33Q28379576-CB6E4712-BB2E-4357-B612-7A34D5049989Q28571336-A6B00D91-8240-471B-B920-9FA9AB4D43A5Q28578035-4D05AFB9-509F-48E8-9B89-4D06F8629D3BQ28591187-A16B72DB-AA34-4D04-B108-9B0BF3907075Q33826100-4C7907E7-F173-47EF-95EE-39F49A2616F6Q34041998-3E9B4776-79D1-4289-B1C0-2854CA6DF8CAQ34186287-5C1BE6E0-4AF3-4114-89B2-08E126D4452FQ34298681-8AAF525E-56F2-46CD-B499-01F9A87B9DF5Q34307642-0A9FD668-05DB-4DD8-8075-E3617FFC2E8AQ34314109-40E189CD-162E-4825-8BBA-5CBBD9A6CA15Q35141133-58F68788-7FFA-43B0-BBC6-D23158A27D45Q35202804-1E6C8B52-0B2B-4CA9-BAD3-461403494C24Q35518745-DE8D765C-C78D-4786-A972-91AC58A0AF57Q35651080-51B90F8E-B308-4A0E-BA7F-161EC5152094Q35669042-CF98D495-A99B-4E0A-A1CC-FFB45286A3A2Q35730397-27BE4A4C-43FB-4771-9862-E85B2EBE1AA9Q35790840-A71F026E-E57D-4439-859B-6C024683D887Q36239537-BDE91C9B-2135-4994-B207-E9515ABD33A9Q36242755-5EA02715-063A-407F-94DE-58EE47115F87Q36295907-4C5D516E-A26F-42C1-986E-ACD8902C8611Q36366486-23396BE6-3B8F-4055-A8CA-AF04E964CA73Q36403830-2AFA1A93-BBC6-42C8-93B1-A57B70C34505Q36458219-A09D63F6-A8CF-4901-866B-7FB747C3BEB6Q36494115-E21DE408-D997-474C-89CE-A149B86CF5FAQ36602261-E9499368-7748-4529-B339-479A92C7910DQ36770768-BADB46B9-2B95-4447-9937-656DA58D9B64Q36829387-520CD802-2ED4-49AF-BABD-ADF6110E7862Q36994635-95630496-C58D-42E6-9F98-1344959FF900Q37094016-2538B4CC-4B04-4FE5-A6CE-D9C978B75DECQ37133514-9D8BF6F7-70E5-4F06-B238-FAF685231E9AQ37289166-72BCEFC6-C29A-4526-B901-442CD5513636Q37494902-42C26523-62B6-4DB3-81AF-8FD84B832CEBQ37579967-58C6E279-71B8-4386-96AD-6B8AAFAA937F
P2860
Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Identification of calcium-acti ...... e of human interleukin 1 alpha
@ast
Identification of calcium-acti ...... e of human interleukin 1 alpha
@en
type
label
Identification of calcium-acti ...... e of human interleukin 1 alpha
@ast
Identification of calcium-acti ...... e of human interleukin 1 alpha
@en
prefLabel
Identification of calcium-acti ...... e of human interleukin 1 alpha
@ast
Identification of calcium-acti ...... e of human interleukin 1 alpha
@en
P2093
P2860
P356
P1476
Identification of calcium-acti ...... e of human interleukin 1 alpha
@en
P2093
Kawasaki H
Kobayashi Y
Matsushima K
Oppenheim JJ
Yamamoto K
P2860
P304
P356
10.1073/PNAS.87.14.5548
P407
P577
1990-07-01T00:00:00Z